Mike Prentice

Gulf International Bank (UK) Ltd. (GIB UK) is an asset management firm headquartered in London, UK. The firm was founded in 1978 and formerly known as Al-Bank Al-Saudi Al-Alami Ltd. They are a wholly owned subsidiary of Gulf International Bank B.S.C., which was established in the Kingdom of Bahrain in 1975. GIB-UK primarily provides portfolio management services to separate accounts of institutions and pension plans.

Arthur Murray International, Inc. owns and operates dance schools. The company consists of approximately 275 franchised studios in eight countries including the United States, Australia, Canada, Germany, Israel, Japan, Italy, and South Africa. Arthur Murray International was founded by Arthur Murray in 1912 and is headquartered in Coral Gables, FL.

Part of DarioHealth Corp., Labstyle Innovation Ltd. is an Israeli company that develops glucose monitoring systems. The company is based in Caesarea, Israel. The company was founded in 2011 by David Weintraub, Shilo Ben-Zeev.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

UltraShape redefines aesthetic medicine by developing, manufacturing and marketing innovative non-invasive technologies for fat cell destruction and body sculpting. The company develops and markets clinically proven safe and effective solutions that enhance the lives of patients. The UltraShape proprietary technology employs pulsed (non-thermal) focused ultrasound that instantly, selectively and permanently destroys fat cells without affecting surrounding structures. Founded in 2000, UltraShape has sold Contour I devices in more than 50 countries, demonstrating safety and efficacy. The UltraShape Contour I system, is authorized for marketing outside the U.S. It is the first clinically proven non-invasive solution that offers measurable lasting body sculpting results for men and women with no need for maintenance treatments. The UltraShape system has been shown to be safe and effective in a multi-center controlled trial and numerous other peer-reviewed published independent clinical studies. The device is designed to produce mechanical, non-thermal, acoustic effects which target and selectively destroy (breakdown) fat cells, leaving surrounding critical structures such as skin, blood vessels, nerves, and connective tissue intact. The latest Contour I V3 system uses Vertical Dynamic Focus™ (VDF) pulsed (non-thermal) focused ultrasound that instantly and permanently destroys fat cells providing patients a convenient noninvasive no-downtime solution to reduce localized fat deposits and body circumference. The UltraShape procedure is based on a natural fat clearance process where triglycerides and cell debris from the destroyed fat cells are processed by the body's natural physiological and metabolic pathways. These pathways are the same that handle fat during weight loss. Results from UltraShape's peer-reviewed published multi-center controlled clinical trial and other independent clinical studies show that the released triglycerides do not accumulate to a clinically significant extent in the blood or liver. Over 200,000 patient treatments have been performed worldwide with the Contour I showing high patient satisfaction while demonstrating safety and efficacy. The UltraShape procedure is guided by proprietary real-time tracking and guidance technology designed to deliver smooth, uniform body contouring results. The software guides the operator through a pres-determined treatment algorithm designed to minimize risk of contour irregularities, a common side effect of invasive and non-invasive procedures. The UltraShape procedure is performed during a convenient, 'walk-in, walk-out' session carried out in an office-based environment; it requires no anesthesia or sedation. After treatment, patients immediately resume their daily routines with no need for maintenance treatments. The UltraShape Contour I received the CE Mark in 2005 and a medical device license from Health Canada in 2007. The Contour I system is not available for sale in the U.S; the Contour Plus system is an investigational product limited by U.S. law to investigational use only.

Golden Technologies, Inc. manufactures lift and recline chairs. Its products include lift chairs, scooters, power wheelchairs and luxury adjustable beds. The company was founded by Robert Golden Sr. and Fred Kiwak in 1985 and is headquartered in Old Forge, PA.

World Trade Center (Holdings), Inc. was founded in 1997 and engages in the trading of goods.

Entourage Effect Capital LLC (Entourage Effect Capital) is a Private Equity firm founded in 2014 by Matthew Hawkins, Andy Sturner & Dov Szapiro. The firm is headquartered in Irving, Dallas.